<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22258259</PMID><DateCompleted><Year>2012</Year><Month>06</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>86</Volume><Issue>7</Issue><PubDate><Year>2012</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1.</ArticleTitle><Pagination><StartPage>3767</StartPage><EndPage>3776</EndPage><MedlinePgn>3767-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.06687-11</ELocationID><Abstract><AbstractText>The recent outbreak of enterovirus 71 (EV71) infected millions of children and caused over 1,000 deaths. To date, neither an effective vaccine nor antiviral treatment is available for EV71 infection. Interferons (IFNs) have been successfully applied to treat patients with hepatitis B and C viral infections for decades but have failed to treat EV71 infections. Here, we provide the evidence that EV71 antagonizes type I IFN signaling by reducing the level of interferon receptor 1 (IFNAR1). We show that the host cells could sense EV71 infection and stimulate IFN-&#x3b2; production. However, the induction of downstream IFN-stimulated genes is inhibited by EV71. Also, only a slight interferon response and antiviral effects could be detected in cells treated with recombinant type I IFNs after EV71 infection. Further studies reveal that EV71 blocks the IFN-mediated phosphorylation of STAT1, STAT2, Jak1, and Tyk2 by reducing IFNAR1. Finally, we identified the 2A protease encoded by EV71 as an antagonist of IFNs and show that the protease activity is required for reducing IFNAR1 levels. Taken together, our study for the first time uncovers a mechanism used by EV71 to antagonize type I IFN signaling and provides new targets for future antiviral strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stanley Ho Center for Emerging Infectious Diseases and Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong,China. mlhe7788@gmail.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Lina</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jin</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jun</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ying</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Marie C</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Kung</LastName><ForeName>Hsiang-Fu</ForeName><Initials>HF</Initials></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Ming-Liang</ForeName><Initials>ML</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507964">IFNAR1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050794">STAT1 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494079">STAT1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050795">STAT2 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>156986-95-7</RegistryNumber><NameOfSubstance UI="D053633">Receptor, Interferon alpha-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="Y">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053633" MajorTopicYN="N">Receptor, Interferon alpha-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050794" MajorTopicYN="N">STAT1 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050795" MajorTopicYN="N">STAT2 Transcription Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22258259</ArticleId><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pii">JVI.06687-11</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>AbuBakar S, et al. 1999. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 61:1&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, et al. 2007. MDA-5 is cleaved in poliovirus-infected cells. J. Virol. 81:3677&#x2013;3684</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866155</ArticleId><ArticleId IdType="pubmed">17267501</ArticleId></ArticleIdList></Reference><Reference><Citation>Barral PM, Sarkar D, Fisher PB, Racaniello VR. 2009. RIG-I is cleaved during picornavirus infection. Virology 391:171&#x2013;176</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743091</ArticleId><ArticleId IdType="pubmed">19628239</ArticleId></ArticleIdList></Reference><Reference><Citation>Brzozka K, Finke S, Conzelmann KK. 2006. Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. J. Virol. 80:2675&#x2013;2683</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1395475</ArticleId><ArticleId IdType="pubmed">16501077</ArticleId></ArticleIdList></Reference><Reference><Citation>Buenz EJ, Howe CL. 2006. Picornaviruses and cell death. Trends Microbiol. 14:28&#x2013;36</Citation><ArticleIdList><ArticleId IdType="pubmed">16337385</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassady KA. 2005. Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection. J. Virol. 79:8707&#x2013;8715</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1168740</ArticleId><ArticleId IdType="pubmed">15994764</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee AV, Roizman B. 2004. Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J. Virol. 78:4185&#x2013;4196</Citation><ArticleIdList><ArticleId IdType="pmc">PMC374303</ArticleId><ArticleId IdType="pubmed">15047834</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehadeh W, Abdulkareem HA. 2010. Difference in susceptibility to MxA protein between a coxsackievirus B1 isolate and prototype, impact of serial cell culture passage. J. Med. Virol. 82:424&#x2013;432</Citation><ArticleIdList><ArticleId IdType="pubmed">20087945</ArticleId></ArticleIdList></Reference><Reference><Citation>Christen V, et al. 2007. Inhibition of alpha interferon signaling by hepatitis B virus. J. Virol. 81:159&#x2013;165</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1797249</ArticleId><ArticleId IdType="pubmed">17065208</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CJ, Lee SD. 2008. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. J. Gastroenterol. Hepatol. 23:512&#x2013;520</Citation><ArticleIdList><ArticleId IdType="pubmed">18397482</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary CM, Donnelly RJ, Soh J, Mariano TM, Pestka S. 1994. Knockout and reconstitution of a functional human type I interferon receptor complex. J. Biol. Chem. 269:18747&#x2013;18749</Citation><ArticleIdList><ArticleId IdType="pubmed">8034627</ArticleId></ArticleIdList></Reference><Reference><Citation>Craxi A, Antonucci G, Camma C. 2006. Treatment options in HBV. J. Hepatol. 44:S77&#x2013;S83</Citation><ArticleIdList><ArticleId IdType="pubmed">16356581</ArticleId></ArticleIdList></Reference><Reference><Citation>de Los Santos T, de Avila Botton S, Weiblen R, Grubman MJ. 2006. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 80:1906&#x2013;1914</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1367153</ArticleId><ArticleId IdType="pubmed">16439546</ArticleId></ArticleIdList></Reference><Reference><Citation>de Los Santos T, Diaz-San Segundo F, Grubman MJ. 2007. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 81:12803&#x2013;12815</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169123</ArticleId><ArticleId IdType="pubmed">17881445</ArticleId></ArticleIdList></Reference><Reference><Citation>Der SD, Zhou A, Williams BR, Silverman RH. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 95:15623&#x2013;15628</Citation><ArticleIdList><ArticleId IdType="pmc">PMC28094</ArticleId><ArticleId IdType="pubmed">9861020</ArticleId></ArticleIdList></Reference><Reference><Citation>de Veer MJ, et al. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69:912&#x2013;920</Citation><ArticleIdList><ArticleId IdType="pubmed">11404376</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd DA, Giddings TH, Jr, Kirkegaard K. 2001. Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. J. Virol. 75:8158&#x2013;8165</Citation><ArticleIdList><ArticleId IdType="pmc">PMC115060</ArticleId><ArticleId IdType="pubmed">11483761</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis S, et al. 2003. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33:388&#x2013;391</Citation><ArticleIdList><ArticleId IdType="pubmed">12590259</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowlkes AL, et al. 2008. Enterovirus-associated encephalitis in the California encephalitis project, 1998&#x2013;2005. J. Infect. Dis. 198:1685&#x2013;1691</Citation><ArticleIdList><ArticleId IdType="pubmed">18959496</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu XY, Kessler DS, Veals SA, Levy DE, Darnell JE., Jr 1990. ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc. Natl. Acad. Sci. U. S. A. 87:8555&#x2013;8559</Citation><ArticleIdList><ArticleId IdType="pmc">PMC54995</ArticleId><ArticleId IdType="pubmed">2236065</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin L, et al. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. U. S. A. 103:8459&#x2013;8464</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1464000</ArticleId><ArticleId IdType="pubmed">16714379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamaguchi T, et al. 2008. Acute encephalitis caused by intrafamilial transmission of enterovirus 71 in adult. Emerg. Infect. Dis. 14:828&#x2013;830</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2600258</ArticleId><ArticleId IdType="pubmed">18439374</ArticleId></ArticleIdList></Reference><Reference><Citation>Heim MH. 1999. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. J. Recept. Signal Transduct. Res. 19:75&#x2013;120</Citation><ArticleIdList><ArticleId IdType="pubmed">10071751</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, et al. 2003. Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc. Natl. Acad. Sci. U. S. A. 100:10872&#x2013;10877</Citation><ArticleIdList><ArticleId IdType="pmc">PMC196895</ArticleId><ArticleId IdType="pubmed">12960379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V, et al. 2006. 5&#x2032;-Triphosphate RNA is the ligand for RIG-I. Science 314:994&#x2013;997</Citation><ArticleIdList><ArticleId IdType="pubmed">17038590</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SY, et al. 1995. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl. Acad. Sci. U. S. A. 92:11284&#x2013;11288</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40616</ArticleId><ArticleId IdType="pubmed">7479980</ArticleId></ArticleIdList></Reference><Reference><Citation>Joachims M, Van Breugel PC, Lloyd RE. 1999. Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J. Virol. 73:718&#x2013;727</Citation><ArticleIdList><ArticleId IdType="pmc">PMC103879</ArticleId><ArticleId IdType="pubmed">9847378</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurgens CK, et al. 2006. 2Apro is a multifunctional protein that regulates the stability, translation and replication of poliovirus RNA. Virology 345:346&#x2013;357</Citation><ArticleIdList><ArticleId IdType="pubmed">16297952</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101&#x2013;105</Citation><ArticleIdList><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempf BJ, Barton DJ. 2008. Poliovirus 2APro increases viral mRNA and polysome stability coordinately in time with cleavage of eIF4G. J. Virol. 82:5847&#x2013;5859</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2395153</ArticleId><ArticleId IdType="pubmed">18400852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler DS, Levy DE, Darnell JE., Jr 1988. Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes. Proc. Natl. Acad. Sci. U. S. A. 85:8521&#x2013;8525</Citation><ArticleIdList><ArticleId IdType="pmc">PMC282490</ArticleId><ArticleId IdType="pubmed">2460869</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Kung SH, Hsu YY, Liu WT. 2002. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J. Gen. Virol. 83:1367&#x2013;1376</Citation><ArticleIdList><ArticleId IdType="pubmed">12029152</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon A, Tough DF. 2002. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14:432&#x2013;436</Citation><ArticleIdList><ArticleId IdType="pubmed">12088676</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Vidal SM. 2002. Functional diversity of Mx proteins: variations on a theme of host resistance to infection. Genome Res. 12:527&#x2013;530</Citation><ArticleIdList><ArticleId IdType="pubmed">11932237</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, et al. 2010. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J. Virol. 84:8051&#x2013;8061</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916543</ArticleId><ArticleId IdType="pubmed">20519382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, et al. 2011. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J. Virol. 85:8811&#x2013;8818</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3165803</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Means R, Lang S, Jung JU. 2007. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J. Virol. 81:2117&#x2013;2127</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1865953</ArticleId><ArticleId IdType="pubmed">17166914</ArticleId></ArticleIdList></Reference><Reference><Citation>Liebig HD, Seipelt J, Vassilieva E, Gradi A, Kuechler E. 2002. A thermosensitive mutant of HRV2 2A proteinase: evidence for direct cleavage of eIF4GI and eIF4GII. FEBS Lett. 523:53&#x2013;57</Citation><ArticleIdList><ArticleId IdType="pubmed">12123803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, et al. 2009. Viral and host proteins involved in picornavirus life cycle. J. Biomed. Sci. 16:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2785775</ArticleId><ArticleId IdType="pubmed">19925687</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu ML, et al. 2005. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 86:3263&#x2013;3269</Citation><ArticleIdList><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, et al. Viral kinetics of Enterovirus 71 in human abdomyosarcoma cells. World J. Gastroenterol. 17:4135&#x2013;4142</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203367</ArticleId><ArticleId IdType="pubmed">22039330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum LC, et al. 1998. Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 133:795&#x2013;798</Citation><ArticleIdList><ArticleId IdType="pubmed">9842048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, et al. 2009. Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus. Mol. Cell Proteomics 8:2582&#x2013;2594</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2773723</ArticleId><ArticleId IdType="pubmed">19671925</ArticleId></ArticleIdList></Reference><Reference><Citation>Manki A, Oda M, Seino Y. 1997. Neurologic diseases of enterovirus infections: polioviruses, coxsackieviruses, echoviruses, and enteroviruses type 68&#x2013;72. Nippon Rinsho 55:849&#x2013;854</Citation><ArticleIdList><ArticleId IdType="pubmed">9103882</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 26:91&#x2013;107</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita K, et al. 1998. Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection. J. Clin. Gastroenterol. 26:135&#x2013;140</Citation><ArticleIdList><ArticleId IdType="pubmed">9563926</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison JM, Racaniello VR. 2009. Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. J. Virol. 83:4412&#x2013;4422</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668472</ArticleId><ArticleId IdType="pubmed">19211759</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller U, et al. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918&#x2013;1921</Citation><ArticleIdList><ArticleId IdType="pubmed">8009221</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanda SK, Baron MD. 2006. Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins. J. Virol. 80:7555&#x2013;7568</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1563703</ArticleId><ArticleId IdType="pubmed">16840335</ArticleId></ArticleIdList></Reference><Reference><Citation>Novick D, Cohen B, Rubinstein M. 1994. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 77:391&#x2013;400</Citation><ArticleIdList><ArticleId IdType="pubmed">8181059</ArticleId></ArticleIdList></Reference><Reference><Citation>Palumbo E. 2009. PEG-interferon in acute and chronic hepatitis C: a review. Am. J. Ther. 16:573&#x2013;578</Citation><ArticleIdList><ArticleId IdType="pubmed">19433975</ArticleId></ArticleIdList></Reference><Reference><Citation>Papon L, et al. 2009. The viral RNA recognition sensor RIG-I is degraded during encephalomyocarditis virus (EMCV) infection. Virology 393:311&#x2013;318</Citation><ArticleIdList><ArticleId IdType="pubmed">19733381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulane CM, et al. 2005. Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain. J. Virol. 79:10180&#x2013;10189</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1182666</ArticleId><ArticleId IdType="pubmed">16051811</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollstedt S, et al. 2004. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J. Virol. 78:3846&#x2013;3850</Citation><ArticleIdList><ArticleId IdType="pmc">PMC374284</ArticleId><ArticleId IdType="pubmed">15047800</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. 2010. NF-kappa B RelA subunit is crucial for early IFN-beta expression and resistance to RNA virus replication. J. Immunol. 185:1720&#x2013;1729</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2910841</ArticleId><ArticleId IdType="pubmed">20610653</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SS, Yip CC, Lau SK, Yuen KY. 2011. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol. Infect. 138:1071&#x2013;1089</Citation><ArticleIdList><ArticleId IdType="pubmed">20056019</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CH, et al. 2010. Enterovirus type 71 2A protease functions as a transcriptional activator in yeast. J. Biomed. Sci. 17:65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2923119</ArticleId><ArticleId IdType="pubmed">20682079</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, et al. 2007. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc. Natl. Acad. Sci. U. S. A. 104:7253&#x2013;7258</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1855380</ArticleId><ArticleId IdType="pubmed">17438296</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, He Y, Chen Y, Kung HF, He ML. 2011. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir. Ther. 16:51&#x2013;58</Citation><ArticleIdList><ArticleId IdType="pubmed">21311108</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Lu J, Kung HF, He ML. 2011. The virology and developments toward control of human enterovirus 71. Crit. Rev. Microbiol. 37:313&#x2013;327</Citation><ArticleIdList><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoneyama M, et al. 2005. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175:2851&#x2013;2858</Citation><ArticleIdList><ArticleId IdType="pubmed">16116171</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu SF, Lloyd RE. 1992. Characterization of the roles of conserved cysteine and histidine residues in poliovirus 2A protease. Virology 186:725&#x2013;735</Citation><ArticleIdList><ArticleId IdType="pubmed">1310193</ArticleId></ArticleIdList></Reference><Reference><Citation>Zurney J, Howard KE, Sherry B. 2007. Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses. J. Virol. 81:13668&#x2013;13680</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2168836</ArticleId><ArticleId IdType="pubmed">17942530</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>